JPS627914B2 - - Google Patents

Info

Publication number
JPS627914B2
JPS627914B2 JP53097832A JP9783278A JPS627914B2 JP S627914 B2 JPS627914 B2 JP S627914B2 JP 53097832 A JP53097832 A JP 53097832A JP 9783278 A JP9783278 A JP 9783278A JP S627914 B2 JPS627914 B2 JP S627914B2
Authority
JP
Japan
Prior art keywords
compound
formula
present
acid
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53097832A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5527105A (en
Inventor
Fumyoshi Ishikawa
Shinichiro Ashida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP9783278A priority Critical patent/JPS5527105A/ja
Priority to IL57923A priority patent/IL57923A/xx
Priority to ZA00793909A priority patent/ZA793909B/xx
Priority to PH22860A priority patent/PH15530A/en
Priority to CS795377A priority patent/CS219256B2/cs
Priority to EP79102869A priority patent/EP0008408B1/en
Priority to DE7979102869T priority patent/DE2961552D1/de
Priority to CA000333380A priority patent/CA1116597A/en
Priority to AU49735/79A priority patent/AU529068B2/en
Priority to GR59809A priority patent/GR73839B/el
Priority to ES483289A priority patent/ES483289A1/es
Priority to DK336779A priority patent/DK153844C/da
Priority to MX798313U priority patent/MX6242E/es
Priority to YU1947/79A priority patent/YU41170B/xx
Priority to SU792798503A priority patent/SU880252A3/ru
Priority to US06/066,113 priority patent/US4284773A/en
Publication of JPS5527105A publication Critical patent/JPS5527105A/ja
Publication of JPS627914B2 publication Critical patent/JPS627914B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP9783278A 1978-08-11 1978-08-11 Imidazothienopyrimidinones compound Granted JPS5527105A (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
JP9783278A JPS5527105A (en) 1978-08-11 1978-08-11 Imidazothienopyrimidinones compound
IL57923A IL57923A (en) 1978-08-11 1979-07-30 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones
ZA00793909A ZA793909B (en) 1978-08-11 1979-07-31 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones
PH22860A PH15530A (en) 1978-08-11 1979-08-03 1,2,3,5 tetrahydroimidazothienopyrimidin 2-ones
CS795377A CS219256B2 (en) 1978-08-11 1979-08-03 Method of making the derivative of the imidazothienpyrimidine
EP79102869A EP0008408B1 (en) 1978-08-11 1979-08-08 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones, a process for their preparation and pharmaceutical compositions
DE7979102869T DE2961552D1 (en) 1978-08-11 1979-08-08 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones, a process for their preparation and pharmaceutical compositions
CA000333380A CA1116597A (en) 1978-08-11 1979-08-08 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones
AU49735/79A AU529068B2 (en) 1978-08-11 1979-08-09 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones
GR59809A GR73839B (enExample) 1978-08-11 1979-08-09
ES483289A ES483289A1 (es) 1978-08-11 1979-08-09 Un procedimiento para la preparacion de 1,2,3,5, tetrahidro-himidazotienopirimidin-2-onas.
DK336779A DK153844C (da) 1978-08-11 1979-08-10 Analogifremgangsmaade til fremstilling af 1,2,3,5-tetrahydroimidazothienopyrimidin-2-oner
MX798313U MX6242E (es) 1978-08-11 1979-08-10 Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas
YU1947/79A YU41170B (en) 1978-08-11 1979-08-10 Process for preparing 1,2,3,5-tetra-hydro-imidazotieno-pyrimidin-2-ones
SU792798503A SU880252A3 (ru) 1978-08-11 1979-08-10 Способ получени 1,2,3,5-тетрагидроимидазотиенопиримидин-2-онов или их солей
US06/066,113 US4284773A (en) 1978-08-11 1979-08-13 1,2,3,5-Tetrahydroimidazothienopyrimidin-2-ones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9783278A JPS5527105A (en) 1978-08-11 1978-08-11 Imidazothienopyrimidinones compound

Publications (2)

Publication Number Publication Date
JPS5527105A JPS5527105A (en) 1980-02-27
JPS627914B2 true JPS627914B2 (enExample) 1987-02-19

Family

ID=14202683

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9783278A Granted JPS5527105A (en) 1978-08-11 1978-08-11 Imidazothienopyrimidinones compound

Country Status (16)

Country Link
US (1) US4284773A (enExample)
EP (1) EP0008408B1 (enExample)
JP (1) JPS5527105A (enExample)
AU (1) AU529068B2 (enExample)
CA (1) CA1116597A (enExample)
CS (1) CS219256B2 (enExample)
DE (1) DE2961552D1 (enExample)
DK (1) DK153844C (enExample)
ES (1) ES483289A1 (enExample)
GR (1) GR73839B (enExample)
IL (1) IL57923A (enExample)
MX (1) MX6242E (enExample)
PH (1) PH15530A (enExample)
SU (1) SU880252A3 (enExample)
YU (1) YU41170B (enExample)
ZA (1) ZA793909B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287340A (en) * 1979-08-27 1981-09-01 Warner-Lambert Company Dihydro-oxo-pyrido[1,2-a]thienopyrimidine compounds
CA1142924A (en) * 1980-06-27 1983-03-15 Hoffmann-La Roche Limited Pyrimidine derivatives
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
GB0808950D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201391254A1 (ru) 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
EP3492106B1 (en) 2013-08-09 2021-02-17 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890321A (en) * 1971-09-20 1975-06-17 Pfizer 6-aryl-5-ethyl-pyrimidin-4-ol compounds useful as intermediates and bronchodilators
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
DE2411273A1 (de) * 1974-03-06 1975-09-18 Schering Ag Neue thieno eckige klammer auf 2,3-d eckige klammer zu pyrimidinone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA1116597A (en) 1982-01-19
US4284773A (en) 1981-08-18
MX6242E (es) 1985-01-28
YU194779A (en) 1983-10-31
JPS5527105A (en) 1980-02-27
DK336779A (da) 1980-02-12
SU880252A3 (ru) 1981-11-07
PH15530A (en) 1983-02-09
AU4973579A (en) 1980-02-14
EP0008408A1 (en) 1980-03-05
EP0008408B1 (en) 1981-12-09
DK153844C (da) 1989-01-30
DE2961552D1 (en) 1982-02-04
ES483289A1 (es) 1980-09-01
IL57923A0 (en) 1979-11-30
YU41170B (en) 1986-12-31
GR73839B (enExample) 1984-05-04
DK153844B (da) 1988-09-12
IL57923A (en) 1982-09-30
ZA793909B (en) 1980-10-29
CS219256B2 (en) 1983-03-25
AU529068B2 (en) 1983-05-26

Similar Documents

Publication Publication Date Title
JPS627914B2 (enExample)
EP0199127B1 (en) 5-(6-imidazo[1,2-a]pyridyl) pyridine derivative
PL136217B1 (en) Method of obtaining novel derivatives of 4-amino-6,7-dimetoxy-2-piprazinoquinazoline
HUT58698A (en) Process for producing sulfanyl-urea-derivatives and pharmaceutical compositions with citostatic compositions containing them5
DE2317716A1 (de) Neue organische verbindungen und verfahren zu deren herstellung
JPH0314315B2 (enExample)
JP3122792B2 (ja) 新規な活性化合物
JP3870298B2 (ja) アミド誘導体
SU893134A3 (ru) Способ получени имидазо-2,1-8-тиазолин-или-тиазин-производных в виде смеси или отдельных изомеров или их кислотно-аддитивных солей
JPH07103127B2 (ja) チエノートリアゾロ―ジアゼピン誘導体、その製造法及びそれを含有する抗喘息、抗アレルギー剤
KR910003153B1 (ko) 7-피페리디노-1,2,3,5-테트라하이드로이미다조[2,1-b]퀴나졸린-2-온의 제조방법
JPH0434549B2 (enExample)
JPH06104668B2 (ja) チエノ‐トリアゾロ‐ジアゼピンのチオメチル誘導体、その製造方法及びそれを含有する医薬組成物
JPH0576479B2 (enExample)
DK167021B1 (da) Substituerede thiacykloalkene oe3,2-baapyridiner, fremgangsmaade til fremstilling deraf og praeparater indeholdende disse
JPH0365349B2 (enExample)
US4609659A (en) 2,6-disubstituted derivatives of 3-nitropyrazines useful as adjuncts to radiation therapy
WO1994017075A1 (en) Diazepin derivatives and antiviral compositions
KR840001316B1 (ko) 이미다조티에노피리미디논 유도체의 제조방법
CA1161847A (en) Imidazole derivatives
JPH0344392A (ja) ４Ｈ‐インドロ〔１，２‐ｄ〕〔１，２，４〕トリアゾロ〔４，３‐ａ〕〔１，４〕ベンゾジアゼピンおよびその製造法
JP2602037B2 (ja) １−アシル−２，３−ジヒドロ−４（１ｈ）−キノリノン−４−オキシム誘導体、その製法およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去用医薬組成物
EP0046990A2 (en) 2-Halogeno-4-alkyl-4,7-dihydro-7-oxo-thieno(3,2-b)-pyridine-6-carboxylic acids, salts thereof at the carboxyl group, pharmaceutical use thereof, and intermediates thereof
GB2171995A (en) Pharmaceutically active 8-heteroarylthio-5, 6, 7, 8-tetrahydroquinolines
JPS643874B2 (enExample)